What this deck covers
This deck focuses on Allergic Reactions And Anaphylaxis, giving you a quick way to review the definitions, rules, and examples that matter most for NREMT AEMT Level.
Study Allergic Reactions And Anaphylaxis in NREMT AEMT Level with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
Which immune mediator is most associated with vasodilation and bronchospasm in anaphylaxis?
Tap card or press Space to flip
Histamine. Released by mast cells and basophils, it triggers increased vascular permeability and smooth muscle contraction.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Allergic Reactions And Anaphylaxis, giving you a quick way to review the definitions, rules, and examples that matter most for NREMT AEMT Level.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Histamine. Released by mast cells and basophils, it triggers increased vascular permeability and smooth muscle contraction.
Answer: 0.15 mg auto-injector. Designed for children under 30 kg to deliver an appropriate reduced dose for safety and effectiveness.
Answer: Severe, systemic allergic reaction with airway or circulatory compromise. Involves rapid onset of life-threatening symptoms due to massive histamine release affecting multiple organ systems.
Answer: Airway compromise (laryngeal edema/bronchospasm). Fatal outcomes often result from asphyxiation due to upper or lower airway obstruction rather than cardiovascular collapse alone.
Answer: Isotonic crystalloid (normal saline or lactated Ringer's). Replenishes intravascular volume lost to increased permeability, aiding in blood pressure restoration.
Answer: Albuterol (beta-2 agonist) via nebulizer. Targets residual bronchospasm by promoting bronchodilation as a supportive measure following primary treatment.
Answer: 0.01 mg/kg IM (max 0.3 mg). Weight-based dosing ensures efficacy while minimizing overdose risk, with a cap aligned to adult standards.
Answer: Corticosteroids (for example, methylprednisolone). Inhibit prolonged inflammatory responses, helping prevent biphasic reactions in the recovery phase.
Answer: 0.3 mg auto-injector. Provides a pre-measured dose suitable for individuals over approximately 30 kg to ensure rapid administration.
Answer: Diphenhydramine (H1 antihistamine). Blocks histamine receptors to mitigate secondary symptoms, though it does not address acute life-threatening features.
Answer: Recent exposure to a known or likely allergen before symptom onset. Establishes temporal association between trigger and symptoms, crucial for confirming the diagnosis in the field.
Answer: Stridor. Results from turbulent airflow through a narrowed upper airway, signaling potential rapid deterioration to complete obstruction.
Answer: Respiratory distress or hypotension after allergen exposure. Indicates systemic involvement beyond localized symptoms, requiring immediate intervention to prevent progression.
Answer: Intramuscular injection into the anterolateral thigh. Provides optimal absorption and onset due to the muscle's vascularity, recommended by guidelines for non-IV access.
Answer: Alpha-1 vasoconstriction raising SVR and blood pressure. Counteracts histamine-induced vasodilation by increasing peripheral resistance, thereby stabilizing hemodynamics.
Answer: Deeper swelling of skin/mucosa, often lips, tongue, or airway. Involves histamine-mediated fluid accumulation in subcutaneous or submucosal layers, potentially compromising airways.
Answer: High-flow oxygen; titrate to adequate oxygenation and ventilation. Supports oxygenation in hypoxemic patients while avoiding hyperoxia, aligned with EMS protocols for respiratory emergencies.
Answer: Asthma exacerbation. Presents with similar respiratory symptoms but usually without cutaneous or gastrointestinal signs of allergy.
Answer: Immune hypersensitivity response to an antigen (allergen). Represents an exaggerated immune system activation by a foreign substance, leading to symptoms like itching or swelling.
Answer: Recurrence of anaphylaxis after initial resolution without re-exposure. Involves a secondary release of mediators hours later, necessitating monitoring even after initial symptom resolution.
Answer: 0.3 mg IM (=0.3 mL of 1:1,000). Delivers a standardized dose to achieve therapeutic adrenergic effects without exceeding safe limits for adults.
Answer: Epinephrine. Acts rapidly to reverse bronchospasm and hypotension through adrenergic effects, making it essential for stabilizing the patient.
Answer: Wheezing. Arises from bronchoconstriction due to inflammatory mediators, indicating lower respiratory tract involvement.
Answer: Raised, itchy wheals (hives) from histamine-mediated skin edema. Occurs when histamine causes fluid leakage into dermal tissues, producing characteristic skin manifestations.
Answer: Beta-2 bronchodilation. Relaxes bronchial smooth muscle to alleviate constriction caused by inflammatory mediators in the airways.